New York A01997 requires the Department of Health to analyze data from the prescription monitoring program registry to identify potential violations.
New York A01997 amends the public health law to mandate that the Department of Health periodically analyze data from the prescription monitoring program registry. The analysis aims to identify information indicating violations of law or breaches of professional standards, including inappropriate prescribing of controlled substances. When relevant, the department must provide identified information to appropriate entities, as permitted under section 3371 of the public health law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.